SI-BONE, Inc. (2K3.F)
| Previous Close | 13.20 |
| Open | 14.40 |
| Bid | 13.90 x 0 |
| Ask | 14.10 x 0 |
| Day's Range | 14.30 - 14.40 |
| 52 Week Range | 13.00 - 26.00 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | 650.471M |
| Beta (5Y Monthly) | 1.22 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.05 |
| Earnings Date | Aug 05, 2024 - Aug 09, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 40.86 |
Insider MonkeySI-BONE, Inc. (NASDAQ:SIBN) Q1 2024 Earnings Call Transcript
SI-BONE, Inc. (NASDAQ:SIBN) Q1 2024 Earnings Call Transcript May 6, 2024 SI-BONE, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to SI-Bone First Quarter 2024 Earnings Conference Call. At this time, all participants are in […]
GlobeNewswireSI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures
SANTA CLARA, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced the first cases completed with the smaller, 9.5 mm diameter, iFuse Bedrock Granite® Implant (Granite 9.5). When placed across the SI joint, the Granite implant provides sacroiliac fusion and spinopelvic fixation as a foundational element for multi-segment spinal fusion. This mileston
